Pollen Allergy – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Pollen Allergy – Drugs In Development, 2024 report and make more profitable business decisions.
Pollen allergy, characterized by sensitivity to the minute particles released seasonally by trees, grasses, and weeds, occurs when these pollen grains disperse through the air in their journey to fertilize plants. The particles frequently infiltrate noses, eyes, ears, and mouths, instigating the onset of allergy symptoms. Sneezing, nasal congestion, and itchy eyes are common manifestations of the immune system’s response to these airborne allergens, impacting individuals susceptible to pollen-induced allergies.
The Pollen Allergy drugs in development market research report provide comprehensive information on the therapeutics under development for Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pollen Allergy and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Pollen Allergy | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 25 molecules, with 24 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Pollen Allergy therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Pollen Allergy pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Pollen Allergy treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Allergy Therapeutics PlcAnergis SA
DC4U BV
Desentum Oy
H. Lundbeck AS
HAL Allergy BV
Immunomic Therapeutics Inc
Kyushu University
Mabylon AG
Regeneron Pharmaceuticals Inc
Revolo Biotherapeutics Ltd
Roxall Medizin GmbH
Worg Pharmaceuticals Hangzhou Co Ltd
Zonhon Biopharma Institute Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pollen Allergy reports